等待開盤 12-08 09:30:00 美东时间
+6.900
+1.37%
The latest update is out from Lennox International ( ($LII) ). On December 4, 2...
12-06 05:47
Barclays analysts struck a cautiously optimistic tone on the U.S. multi-industry sector for 2026, forecasting a modest rebound in organic growth and earnings after a lackluster 2025, even as they main...
12-06 02:03
Lennox (LII) declares $1.30/share quarterly dividend, in line with previous. Forward yield 1.03% Payable Jan. 15; for shareholders of record Dec. 31; ex-div Dec. 31. See LII Dividend Scorecard, Yield ...
12-05 23:04
DALLAS, Dec. 5, 2025 /PRNewswire/ -- The Lennox board of directors (NYSE: LII) approved a quarterly cash dividend of $1.30 per share of common stock, payable January 15, 2026, to stockholder...
12-05 22:56
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Wells Fargo analyst Joseph O'Dea maintains Lennox Intl (NYSE:LII) with a Equal-Weight and lowers the price target from $545 to $525.
12-04 23:21
An update from Smartgroup Corporation Ltd ( ($AU:SIQ) ) is now available. Lenno...
11-28 15:58
Wolfe Research analyst Nigel Coe upgrades Lennox Intl (NYSE:LII) from Underperform to Peer Perform.
11-13 21:03
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Neuropace, Inc. (($NPCE)) announced an update on their ongoing clinical study. ...
10-28 03:49